Crossmark

Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)

Crossref DOI link: https://doi.org/10.1007/s00228-024-03767-6

Published Online: 2024-10-23

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Akagi, Tomoaki

Hamano, Hirofumi

Miyamoto, Hirotaka

Takeda, Tatsuaki

Zamami, Yoshito

Ohyama, Kaname
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 1 August 2024

Accepted: 11 October 2024

First Online: 23 October 2024

Declarations

:

: This study was conducted in accordance with WHO policy and UMC guidelines.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below